These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6121522)

  • 41. Vecuronium and atracurium.
    Rosewarne FA
    Br J Anaesth; 1983 Oct; 55(10):1042-3. PubMed ID: 6138052
    [No Abstract]   [Full Text] [Related]  

  • 42. Determination of Org NC 45 (a myoneural blocking agent) in human plasma using high-performance normal-phase liquid chromatography.
    Paanakker JE; van de Laar GL
    J Chromatogr; 1980 Oct; 183(4):459-66. PubMed ID: 6107302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted.
    Smit JW; Schinkel AH; Weert B; Meijer DK
    Br J Pharmacol; 1998 May; 124(2):416-24. PubMed ID: 9641561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of vecuronium bromide administered at a constant rate during renal transplantation].
    Richard JP; Conil JM; Antonini A; Bareille P
    Cah Anesthesiol; 1986; 34(2):125-6. PubMed ID: 2872948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of vecuronium and pancuronium on release of lactate dehydrogenase in rat isolated diaphragm, liver, kidney and heart.
    Wali FA; Makinde V
    Acta Physiol Hung; 1991; 78(2):127-33. PubMed ID: 1687303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the cardiovascular actions of ORG NC 45 with those produced by other non-depolarizing neuromuscular blocking agents in experimental animals.
    Marshall RJ; McGrath JC; Miller RD; Docherty JR; Lamar JC
    Br J Anaesth; 1980; 52 Suppl 1():21S-32S. PubMed ID: 6107101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of changes in acid-base balance on neuromuscular blockade produced by ORG-NC 45.
    Funk DI; Crul JF; Pol FM
    Acta Anaesthesiol Scand; 1980 Apr; 24(2):119-24. PubMed ID: 6104411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of the human "isolated arm" preparation to indicate qualitative aspects of a new neuromuscular blocking agent, ORG NC 45.
    Bencini A; Agoston S; Ket J
    Br J Anaesth; 1980; 52 Suppl 1():43S-47S. PubMed ID: 6107105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary clinical observations with ORG NC 45.
    Schaer H; Hossli G
    Br J Anaesth; 1980; 52 Suppl 1():65S. PubMed ID: 6107111
    [No Abstract]   [Full Text] [Related]  

  • 52. ORG NC 45: initial experiences.
    Swen J
    Br J Anaesth; 1980; 52 Suppl 1():66S-67S. PubMed ID: 6107112
    [No Abstract]   [Full Text] [Related]  

  • 53. A new neuromuscular blocking drug, ORG NC 45. A pilot study in man.
    Baird WL; Herd D
    Br J Anaesth; 1980; 52 Suppl 1():61S-62S. PubMed ID: 6107108
    [No Abstract]   [Full Text] [Related]  

  • 54. Org NC 45 reduces quantal release of acetylcholine (a preliminary communication).
    Torda TA; Kiloh N
    Anaesth Intensive Care; 1982 May; 10(2):127-9. PubMed ID: 6125106
    [No Abstract]   [Full Text] [Related]  

  • 55. First clinical experiences with ORG NC 45.
    Crul JF; Booij LH
    Br J Anaesth; 1980; 52 Suppl 1():49S-52S. PubMed ID: 6107106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The metabolism of pancuronium in man].
    Buzello W
    Anaesthesist; 1975 Jan; 24(1):13-8. PubMed ID: 1130635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary review of the interactions of ORG NC 45 with anaesthetics and antibiotics in animals.
    Krieg N; Rutten JM; Crul JF; Booij LH
    Br J Anaesth; 1980; 52 Suppl 1():33S-36S. PubMed ID: 6107103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The clinical evaluation of Org-NC45 in pediatric anaesthesia].
    Obara H; Hoshina H; Chuma R; Tanaka O; Morikawa S; Iwai S
    Masui; 1985 Jun; 34(6):799-804. PubMed ID: 2863399
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of steroidal muscle relaxants in isolated perfused rat liver.
    Mol WE; Rombout F; Paanakker JE; Oosting R; Scaf AH; Meijer DK
    Biochem Pharmacol; 1992 Oct; 44(7):1453-9. PubMed ID: 1358074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.